Elizabeth Rochford, NP
Gerontology · Burr Ridge, ILNPI 1114950409
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 30 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Acadia Pharmaceuticals Inc at 27.5% of the total. Reporting peaked in 2021 at $284 and has fallen 74.0% since, to $74 in 2025.
Across 30 payments — averaging $21.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$175
- Neurocrine Biosciences, Inc.$87
- Abbott$74
- Otsuka America Pharmaceutical, Inc.$50
- Johnson & Johnson$49
- Lilly USA, LLC$46
- plus $157 from 8 others
What the payments were for
- Food & beverage$636100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 11 | $175 |
| Neurocrine Biosciences, Inc. | 2 | $87 |
| Abbott | 1 | $74 |
| Otsuka America Pharmaceutical, Inc. | 1 | $50 |
| Johnson & Johnson | 3 | $49 |
| Lilly USA, LLC | 2 | $46 |
| AstraZeneca | 2 | $31 |
| Astellas Pharma US Inc | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Mylan Specialty L.p. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Urovant Sciences Inc | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $13 |
| Biogen | 1 | $13 |
How this compares
$637 in reported general payments places this provider in the 70th percentile of 180 gerontology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 21 | $461 |
| Tamsulosin Hcl | 15 | $455 |
| Metoprolol Succinate | 19 | $249 |
| Finasteride | 14 | $111 |
| Quetiapine Fumarate | 15 | $74 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Burr Ridge
- Joseph StokesChicago$16K
- Stephanie VerderameRockford$15K
- Megan BonisNiles$15K
- Cheryl RogersKankakee$15K
- June LosurdoHinsdale$9K
- Hayley MillsMoline$7K
- Carlyn NewellOlympia Fields$7K
- Ann WaldronMatteson$6K
- Kristin RyanArlington Heights$6K
- Rhonda JohnsonRockford$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.